METHOD FOR PRODUCING CYCLOHEXANE DERIVATIVE
    5.
    发明公开
    METHOD FOR PRODUCING CYCLOHEXANE DERIVATIVE 审中-公开
    VERFAHREN ZUR HERSTELLUNG EINES CYCLOHEXANDERIVATS

    公开(公告)号:EP2505584A1

    公开(公告)日:2012-10-03

    申请号:EP10833197.6

    申请日:2010-11-24

    IPC分类号: C07D263/58 C07D277/82

    CPC分类号: C07D263/58 C07D277/82

    摘要: A process for the preparation of a compound of formula (I):

    wherein R 1 is each independently halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 haloalkoxy or C1-C6 alkylcarbonyl,
    R 3 is C1-C6 alkyl; C3-C8 cycloalkyl; or phenyl optionally substituted with one or more substituents selected from the group consisting of halogen, C1-C6 alkyl; C1-C6 alkoxy, C1-C6 haloalkyl and C1-C6 haloalkoxy,
    n is an integer of 0 to 2,
    X is S atom or O atom,

    its salt or solvate thereof characterized by reacting a compound of formula (IV):

    wherein R 1 , n and X have the same meaning as defined above, and
    R 2 is C1-C6 alkyl; C1-C6 haloalkyl; or phenyl optionally substituted with one or more substituents selected from the group consisting of halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 haloalkoxy and nitro,

    with a compound of formula (V):

    wherein R 3 has the same meaning as defined above.

    摘要翻译: 一种制备式(I)化合物的方法:其中R 1各自独立地为卤素,C 1 -C 6烷基,C 1 -C 6烷氧基,C 1 -C 6卤代烷基,C 1 -C 6卤代烷氧基或C 1 -C 6烷基羰基,R 3为 C1-C6烷基; C3-C8环烷基; 或任选被一个或多个选自以下的取代基取代的苯基:卤素,C 1 -C 6烷基; C1-C6烷氧基,C1-C6卤代烷基和C1-C6卤代烷氧基,n是0-2的整数,X是S原子或O原子,其盐或溶剂合物的特征在于使式(Ⅳ)化合物:其中R 1,n和X具有与上述相同的含义,R 2是C 1 -C 6烷基; C1-C6卤代烷基; 或任选被一个或多个选自卤素,C 1 -C 6烷基,C 1 -C 6烷氧基,C 1 -C 6卤代烷基,C 1 -C 6卤代烷氧基和硝基的取代基取代的苯基与式(Ⅴ)化合物反应:其中R 3具有与上述相同的含义。

    AROMATIC HETEROCYCLIC FIVE-MEMBERED RING DERIVATIVE HAVING TRPV4 INHIBITORY ACTIVITY
    6.
    发明公开
    AROMATIC HETEROCYCLIC FIVE-MEMBERED RING DERIVATIVE HAVING TRPV4 INHIBITORY ACTIVITY 审中-公开
    具有TRPV4抑制活性的芳香族杂环五员环衍生物

    公开(公告)号:EP2832731A1

    公开(公告)日:2015-02-04

    申请号:EP13769523.5

    申请日:2013-03-26

    摘要: The present invention is related to a compound represented by formula (I)

    wherein R 1 is a hydrogen atom, substituted or unsubstituted alkyl, substituted or unsubstituted aromatic carbocyclyl, or the like; X is -N(R 3 )-, -O-, or -S-; Y is =C(R 4 )-, or =N-; Z is -N(R 7 )-, -O-, or -S-;
    R 2 is substituted or unsubstituted alkyloxy, or the like, or a group represented by the following formula: -(CR 2a R 2b ) n -R 2c , wherein R 2a is each independently a hydrogen atom, halogen, or the like; R 2b is each independently a hydrogen atom, halogen, or the like; R 2a and R 2b which are attached to the same carbon atom may be taken together to form oxo, a substituted or unsubstituted non-aromatic carbocycle, or the like; two of R 2a which are attached to the adjacent carbon atoms and/or two of R 2b which are attached to the adjacent carbon atoms may be taken together to form a bond; R 2c is substituted or unsubstituted aromatic carbocyclyl, or the like; n is an integer from 1 to 3;
    R 3 and R 7 are each independently a hydrogen atom, substituted or unsubstituted alkyl, or the like;
    R 4 and R 5 are each independently a hydrogen atom, halogen, substituted or unsubstituted alkyl, or the like;
    R 6 is a hydrogen atom, halogen, substituted or unsubstituted alkyl, or the like,
    or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising thereof.

    摘要翻译: 本发明涉及由式(I)表示的化合物,其中R 1为氢原子,取代或未取代的烷基,取代或未取代的芳族碳环基等; X是-N(R3) - , - O-或-S-; Y是= C(R4) - ,或= N-; Z是-N(R 7) - , - O-或-S-; R2为取代或未取代的烷氧基等,或由下式表示的基团: - (CR2aR2b)n-R2c,其中R2a各自独立地为氢原子,卤素等; R 2b各自独立地为氢原子,卤素等; 连接到相同碳原子上的R2a和R2b可以一起形成氧代,取代或未取代的非芳族碳环等; 与相邻碳原子连接的R2a中的两个和/或与相邻碳原子连接的R2b中的两个可结合在一起形成键; R2c是取代或未取代的芳族碳环基等; n是1至3的整数; R3和R7各自独立地为氢原子,取代或未取代的烷基等; R4和R5各自独立地为氢原子,卤素,取代或未取代的烷基等; R6是氢原子,卤素,取代或未取代的烷基等,或其药学上可接受的盐或包含其的药物组合物。